香雪制药
(300147)
| 流通市值：23.73亿 | | | 总市值：23.87亿 |
| 流通股本：6.57亿 | | | 总股本：6.61亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,728,181,516.45 | 1,201,352,488.59 | 588,724,855.57 | 2,187,069,901.4 |
| 营业收入 | 1,728,181,516.45 | 1,201,352,488.59 | 588,724,855.57 | 2,187,069,901.4 |
| 二、营业总成本 | 1,805,286,778.67 | 1,221,632,755.44 | 587,997,301.38 | 2,578,521,275.62 |
| 营业成本 | 1,103,905,830.52 | 753,621,079.15 | 354,953,740.86 | 1,644,557,065.25 |
| 税金及附加 | 19,591,589.51 | 13,114,872.7 | 5,757,040.87 | 22,969,434.46 |
| 销售费用 | 244,646,494.82 | 164,895,444.21 | 84,607,348.24 | 333,141,258.26 |
| 管理费用 | 208,030,209.23 | 134,603,624.8 | 66,949,753.46 | 270,551,080.44 |
| 研发费用 | 44,798,579.22 | 29,047,025.76 | 17,941,867.46 | 94,792,768.61 |
| 财务费用 | 184,314,075.37 | 126,350,708.82 | 57,787,550.49 | 212,509,668.6 |
| 其中:利息费用 | 178,673,741.01 | 123,139,086.96 | 55,754,220.94 | 213,201,429.83 |
| 其中:利息收入 | 895,064.96 | 870,405.1 | 1,117,242.53 | 3,913,373.02 |
| 加:公允价值变动收益 | -1,477,283.31 | -92,754.44 | -79,954.89 | -11,875.95 |
| 加:投资收益 | -471,139.38 | 913,362.95 | 693,176.79 | 47,329,285.79 |
| 资产处置收益 | 138,317.26 | 136,315.2 | 136,315.2 | 4,879,080.57 |
| 资产减值损失(新) | -47,105,449.45 | -43,580,079.92 | - | -138,577,579.25 |
| 信用减值损失(新) | -4,421,996.2 | -1,801,188.22 | -1,294,751.02 | -21,759,274.78 |
| 其他收益 | 30,910,691.98 | 23,998,896.53 | 14,976,231.97 | 32,596,664.38 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -99,532,121.32 | -40,705,714.75 | 15,158,572.24 | -466,995,073.46 |
| 加:营业外收入 | 762,686.6 | 593,213.3 | 182,964.31 | 1,208,751.53 |
| 减:营业外支出 | 28,605,965.26 | 18,147,565.91 | 6,828,584.34 | 48,929,892.53 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -127,375,399.98 | -58,260,067.36 | 8,512,952.21 | -514,716,214.46 |
| 减:所得税费用 | 4,515,714.45 | 130,367.64 | 231,135.02 | -6,795,018.33 |
| 六、净利润 | -131,891,114.43 | -58,390,435 | 8,281,817.19 | -507,921,196.13 |
| 持续经营净利润 | -131,891,114.43 | -58,390,435 | 8,281,817.19 | -507,921,196.13 |
| 归属于母公司股东的净利润 | -146,072,910.4 | -65,993,300.35 | 4,536,891.13 | -533,158,456.93 |
| 少数股东损益 | 14,181,795.97 | 7,602,865.35 | 3,744,926.06 | 25,237,260.8 |
| (一)基本每股收益 | -0.22 | -0.1 | 0.01 | -0.81 |
| (二)稀释每股收益 | -0.22 | -0.1 | 0.01 | -0.81 |
| 八、其他综合收益 | -2,770,494.08 | -2,705,023.53 | -4,382,701.85 | -8,061,045.79 |
| 归属于母公司股东的其他综合收益 | -2,770,494.08 | -2,705,023.53 | -4,382,701.85 | -7,261,045.79 |
| 九、综合收益总额 | -134,661,608.51 | -61,095,458.53 | 3,899,115.34 | -515,982,241.92 |
| 归属于母公司股东的综合收益总额 | -148,843,404.48 | -68,698,323.88 | 154,189.28 | -540,419,502.72 |
| 归属于少数股东的综合收益总额 | 14,181,795.97 | 7,602,865.35 | 3,744,926.06 | 24,437,260.8 |
| 公告日期 | 2023-10-28 | 2023-08-29 | 2023-04-28 | 2023-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |